Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome

Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome

Type B insulin resistance syndrome (TBIR) is a rare disease characterized by refractory diabetes due to severe insulin resistance caused by anti-insulin receptor autoantibodies, and a standard treatment regimen for TBIR has not been established, leading to therapeutic difficulties and high mortality...

Full description

Bibliographic Details
Main Authors: Arata Osanami, Masatoshi Kanda, Tatsuya Sato, Chikako Akazawa, Shuhei Baba, Hiroaki Komatsu, Kazuyuki Murase, Tomohisa Yamashita, Toshiyuki Yano
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Endocrinology
Subjects:
type B insulin resistance (TBIR)
double-filtration plasma apheresis
rituximab
sensor-augmented pump (SAP)
ketosis
catabolism
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.997296/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.997296/full

Similar Items